Blog Posts

Two More Drugmakers End 340B Contract Pharmacy Restrictions in Arkansas After Appeals Court Decision

EMD Serono lifted 340B contract pharmacy restrictions in Arkansas in response to a state law. Shortly after, Sanofi also updated its policy in the state.
Drugmakers EMD Serono and Sanofi will lift 340B contract pharmacy restrictions in Arkansas after a federal appeals court upheld a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Key Considerations for the SUSTAIN 340B Act

SPONSORED CONTENT

On February 2, six senators known as the “Gang of Six” – John Thune, Debbie Stabenow, Shelley Moore Capito, Tammy Baldwin, Jerry Moran and Ben Cardin – unveiled a discussion draft bill intended to preserve the 340B program and codify in statute many of its operational provisions. The draft bill, titled Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act (SUSTAIN 340B Act or SUSTAIN Act), was accompanied by an explanatory statement and request for information (RFI), with many questions for Covered Entities (CEs) to review and provide further responses to the Gang of Six.

Stakeholders were asked to review the RFI and provide additional responses, with comments due by April 1. As we approach the deadline for comments, it’s crucial to delve into the most critical elements of the bill and discuss next steps for 340B stakeholders.

340B’s Purpose (Section 2)

Read More »

Connecticut, Minnesota Join 20 Other States with 340B Contract Pharmacy Bills Introduced This Session

Connecticut is the latest state to have a 340B contract pharmacy bill introduced this legislative session.
A Connecticut state senate committee this week amended a bill to add provisions barring drugmaker 340B contract pharmacy restrictions in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hawaii Lawmakers Urge State Health Department to Protect 340B

Hawaii legislators in the house and senate introduced resolutions that urged the state health department to act to protect the 340B program.
Influential Hawaiian state legislators have introduced resolutions that call on the state health department to “ensure continued access to affordable [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Ballot Initiative Targets Big 340B Provider Serving HIV Population

Tom Myers, general counsel for AHF, said a California ballot measure is intended as retaliation against the HIV/AIDS group.
A California ballot initiative aims to codify the California governor’s 2019 shift of the Medicaid program’s prescription drug benefit from [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B INDUSTRY LEADER SPOTLIGHT

Jaclyn Hahn, Director of Pharmacy, Ravin Consultants

Jaclyn Hahn

Q: Where did you grow up?

I grew up at the Jersey shore. After college, I moved to Santa Barbara, CA where I lived for 13 years before recently

Read More »

Two More Drug Companies Restore 340B Contract Pharmacy Access in Arkansas After Court Decision; Enforcement Action Imminent Against Others

As AID prepares to initiate enforcement of Arkansas' 340B contract pharmacy law, two more drugmakers announced they would exempt state providers from their contract pharmacy policies.
Months after nine drug manufacturers restored 340B contract pharmacy access in Arkansas, two more companies have announced they will exempt [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Maryland House Unanimously Passes 340B Contract Pharmacy Bill

Maryland is the sixth state with a 340B contract pharmacy bill to pass at least one legislative chamber this session.
The Maryland state house yesterday unanimously passed a bill that would prohibit drugmaker 340B contract pharmacy restrictions in the state. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Reports Critique Financial Dynamics of 340B Program

Recent reports from 46brooklyn, a nonprofit think tank, and IQVIA, a drug industry analytics firm, criticized the financial dynamics of 340B.
The 340B program may increase medication costs for self-insured employers, a recent study from a pharmaceutical industry outsourcing and analytics [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospitals’ Low-Income Prostate Cancer Patients Had Better Adherence

Dr. Kassem Faraj and his co-authors at the University of Michigan found 340B was associated with better treatment adherence for more vulnerable prostate cancer patients.
Although 340B participation did not correlate to the start of costly treatment for men with advanced prostate cancer enrolled in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer